Thrivent Financial for Lutherans’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-28,221
| Closed | -$2.62M | – | 2569 |
|
|
2021
Q4 | $2.62M | Sell |
28,221
-65,389
| -70% | -$4.31M | 0.01% | 1215 |
|
|
2021
Q3 | $5.58M | Buy |
93,610
+21,840
| +30% | +$1.29M | 0.01% | 850 |
|
|
2021
Q2 | $4.89M | Buy |
71,770
+1,170
| +2% | +$76.3K | 0.01% | 928 |
|
|
2021
Q1 | $4.9M | Sell |
70,600
-2,556
| -3% | -$197K | 0.01% | 924 |
|
|
2020
Q4 | $5.62M | Buy |
73,156
+8,029
| +12% | +$602K | 0.01% | 822 |
|
|
2020
Q3 | $4.87M | Sell |
65,127
-1,855
| -3% | -$124K | 0.01% | 806 |
|
|
2020
Q2 | $4.22M | Buy |
66,982
+418
| +0.6% | +$23K | 0.01% | 761 |
|
|
2020
Q1 | $2.8M | Buy |
66,564
+171
| +0.3% | +$7.84K | 0.01% | 819 |
|
|
2019
Q4 | $3.02M | Buy |
66,393
+7,014
| +12% | +$332K | 0.01% | 859 |
|
|
2019
Q3 | $2.72M | Buy |
59,379
+1,751
| +3% | +$98.4K | 0.01% | 851 |
|
|
2019
Q2 | $3.38M | Buy |
57,628
+738
| +1% | +$38.1K | 0.01% | 783 |
|
|
2019
Q1 | $2.55M | Buy |
56,890
+1,257
| +2% | +$57.7K | 0.01% | 853 |
|
|
2018
Q4 | $2.17M | Buy |
55,633
+203
| +0.4% | +$7.97K | 0.01% | 810 |
|
|
2018
Q3 | $2.55M | Sell |
55,430
-6,680
| -11% | -$271K | 0.01% | 809 |
|
|
2018
Q2 | $2.71M | Buy |
62,110
+7,136
| +13% | +$307K | 0.01% | 804 |
|
|
2018
Q1 | $2.17M | Buy |
+54,974
| New | +$2.14M | 0.01% | 867 |
|
Thrivent Financial for Lutherans's ARNA Position: Q1 2022 in Review
Thrivent Financial for Lutherans sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 28,221 shares — an estimated $2.62M sold.
Thrivent Financial for Lutherans first reported a position in ARNA in Q1 2018 and held it in 16 quarters. The position peaked at $5.62M in Q4 2020. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Thrivent Financial for Lutherans reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Thrivent Financial for Lutherans sold 28,221 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $2.62M.
- Thrivent Financial for Lutherans first reported a position in Arena Pharmaceuticals Inc in Q1 2018 and held it in 16 quarters.
- Thrivent Financial for Lutherans's Arena Pharmaceuticals Inc position peaked at $5.62M in Q4 2020.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Thrivent Financial for Lutherans's 13F filing for Q1 2022, filed 13 May 2022.